Form 8-K - Current report:
SEC Accession No. 0001193125-21-364697
Filing Date
2021-12-22
Accepted
2021-12-22 13:54:01
Documents
13
Period of Report
2021-12-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d264503d8k.htm   iXBRL 8-K 25046
2 EX-99.1 d264503dex991.htm EX-99.1 58389
  Complete submission text file 0001193125-21-364697.txt   210536

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neog-20211221.xsd EX-101.SCH 2887
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20211221_lab.xml EX-101.LAB 17375
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20211221_pre.xml EX-101.PRE 10950
7 EXTRACTED XBRL INSTANCE DOCUMENT d264503d8k_htm.xml XML 3262
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 211512703
SIC: 2835 In Vitro & In Vivo Diagnostic Substances